These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 16452200
1. Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells. Garces CA, Kurenova EV, Golubovskaya VM, Cance WG. Cancer Res; 2006 Feb 01; 66(3):1446-54. PubMed ID: 16452200 [Abstract] [Full Text] [Related]
2. TAE226-induced apoptosis in breast cancer cells with overexpressed Src or EGFR. Golubovskaya VM, Virnig C, Cance WG. Mol Carcinog; 2008 Mar 01; 47(3):222-34. PubMed ID: 17849451 [Abstract] [Full Text] [Related]
3. Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer. Wu Y, Zhong Z, Huber J, Bassi R, Finnerty B, Corcoran E, Li H, Navarro E, Balderes P, Jimenez X, Koo H, Mangalampalli VR, Ludwig DL, Tonra JR, Hicklin DJ. Clin Cancer Res; 2006 Nov 01; 12(21):6573-84. PubMed ID: 17085673 [Abstract] [Full Text] [Related]
4. Intrinsic FAK activity and Y925 phosphorylation facilitate an angiogenic switch in tumors. Mitra SK, Mikolon D, Molina JE, Hsia DA, Hanson DA, Chi A, Lim ST, Bernard-Trifilo JA, Ilic D, Stupack DG, Cheresh DA, Schlaepfer DD. Oncogene; 2006 Sep 28; 25(44):5969-84. PubMed ID: 16682956 [Abstract] [Full Text] [Related]
5. Expression of MLN64 influences cellular matrix adhesion of breast cancer cells, the role for focal adhesion kinase. Cai W, Ye L, Sun J, Mansel RE, Jiang WG. Int J Mol Med; 2010 Apr 28; 25(4):573-80. PubMed ID: 20198306 [Abstract] [Full Text] [Related]
6. Tumor growth inhibition by synthetic and expressed siRNA targeting focal adhesion kinase. Tsutsumi K, Kasaoka T, Park HM, Nishiyama H, Nakajima M, Honda T. Int J Oncol; 2008 Jul 28; 33(1):215-24. PubMed ID: 18575768 [Abstract] [Full Text] [Related]
7. Wilms' tumor 1 protein and focal adhesion kinase mediate keratinocyte growth factor signaling in breast cancer cells. Zang XP, Pento JT, Tari AM. Anticancer Res; 2008 Jul 28; 28(1A):133-7. PubMed ID: 18383836 [Abstract] [Full Text] [Related]
8. A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth. Shi Q, Hjelmeland AB, Keir ST, Song L, Wickman S, Jackson D, Ohmori O, Bigner DD, Friedman HS, Rich JN. Mol Carcinog; 2007 Jun 28; 46(6):488-96. PubMed ID: 17219439 [Abstract] [Full Text] [Related]
9. Focal adhesion kinase and protein kinase B cooperate to suppress doxorubicin-induced apoptosis of breast tumor cells. van Nimwegen MJ, Huigsloot M, Camier A, Tijdens IB, van de Water B. Mol Pharmacol; 2006 Oct 28; 70(4):1330-9. PubMed ID: 16825486 [Abstract] [Full Text] [Related]
10. Effect of triptolide on focal adhesion kinase and survival in MCF-7 breast cancer cells. Tan BJ, Tan BH, Chiu GN. Oncol Rep; 2011 Nov 28; 26(5):1315-21. PubMed ID: 21805042 [Abstract] [Full Text] [Related]
11. Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model. Mitra SK, Lim ST, Chi A, Schlaepfer DD. Oncogene; 2006 Jul 27; 25(32):4429-40. PubMed ID: 16547501 [Abstract] [Full Text] [Related]
12. Phosphorylation of focal adhesion kinase promotes extravasation of breast cancer cells. Earley S, Plopper GE. Biochem Biophys Res Commun; 2008 Feb 08; 366(2):476-82. PubMed ID: 18073135 [Abstract] [Full Text] [Related]
13. Focal adhesion kinase (FAK) immunocytochemical expression in breast ductal invasive carcinoma (DIC): correlation with clinicopathological parameters and tumor proliferative capacity. Theocharis SE, Klijanienko JT, Padoy E, Athanassiou S, Sastre-Garau XX. Med Sci Monit; 2009 Aug 08; 15(8):BR221-6. PubMed ID: 19644410 [Abstract] [Full Text] [Related]
14. Signal transduction by focal adhesion kinase in cancer. Zhao J, Guan JL. Cancer Metastasis Rev; 2009 Jun 08; 28(1-2):35-49. PubMed ID: 19169797 [Abstract] [Full Text] [Related]
15. Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2. Roberts N, Kloos B, Cassella M, Podgrabinska S, Persaud K, Wu Y, Pytowski B, Skobe M. Cancer Res; 2006 Mar 01; 66(5):2650-7. PubMed ID: 16510584 [Abstract] [Full Text] [Related]
16. Structural basis for the interaction between focal adhesion kinase and CD4. Garron ML, Arthos J, Guichou JF, McNally J, Cicala C, Arold ST. J Mol Biol; 2008 Feb 01; 375(5):1320-8. PubMed ID: 18078954 [Abstract] [Full Text] [Related]
17. The 7-amino-acid site in the proline-rich region of the N-terminal domain of p53 is involved in the interaction with FAK and is critical for p53 functioning. Golubovskaya VM, Finch R, Zheng M, Kurenova EV, Cance WG. Biochem J; 2008 Apr 01; 411(1):151-60. PubMed ID: 18215142 [Abstract] [Full Text] [Related]
18. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms. Kodama M, Kitadai Y, Tanaka M, Kuwai T, Tanaka S, Oue N, Yasui W, Chayama K. Clin Cancer Res; 2008 Nov 15; 14(22):7205-14. PubMed ID: 19010837 [Abstract] [Full Text] [Related]
19. A role for focal adhesion kinase signaling in tumor necrosis factor-alpha-dependent matrix metalloproteinase-9 production in a cholangiocarcinoma cell line, CCKS1. Mon NN, Hasegawa H, Thant AA, Huang P, Tanimura Y, Senga T, Hamaguchi M. Cancer Res; 2006 Jul 01; 66(13):6778-84. PubMed ID: 16818654 [Abstract] [Full Text] [Related]
20. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1. Starzec A, Vassy R, Martin A, Lecouvey M, Di Benedetto M, Crépin M, Perret GY. Life Sci; 2006 Nov 17; 79(25):2370-81. PubMed ID: 16959272 [Abstract] [Full Text] [Related] Page: [Next] [New Search]